Select Criteria: Super Track = Live Sessions

Friday, September 11, 3:00 PM - 4:00 PM

    The Young Investigator Session is hosted for researchers who are 35 years old or less. The session consists of 4 oral presentations from research submitted for the conference by young researchers followed by 20 minutes of Q&A from the participants. The official hour of the ILCA 2020 Virtual Conference is CEST... Read More
    Speaker(s)
    Oral Presenter
    Catherine Willoughby
    O-04: Cabozantinib Enhances The Efficacy And Immune Activity Of Anti-Pd1 Therapy In A Murine Model Of Hepatocellular Carcinoma
    Oral Presenter
    Helena Degroote
    O-01: International, multicenter study on the outcome of locoregional therapy before liver transplant for hepatocellular carcinoma extending the Milan criteria
    Oral Presenter
    Hyo-Jin Kang
    O-03: Prospective Intra-Individual Comparison Of Contrast-Enhanced Ultrasound With Sulfur Hexafluoride And Perfluorobutane For Diagnosis Of Hepatocellular
    Moderator
    Morris Sherman
    Professor of Medicine at University of Toronto. ILCA Past President
    Oral Presenter
    Saur Hajiev
    O-02: Impact Of Age On Sorafenib Outcomes In Hepatocellular Carcinoma: An International Cohort Study.
    • General Session

    Friday, September 11, 4:05 PM - 4:35 PM

      10 Top scored clinical e-Posters presenters  will participate on this LIVE Question & Answer session where participants and specialists will ask poster presenters about findings described in their poster. The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local :  https://www.timeanddate.com/worldclock/converter-classic.html ...
      Speaker(s)
      Poster Presenter
      Amit G.. Singal
      P-47: Benefits And Harms Of Hepatocellular Carcinoma Surveillance In A Prospective Cohort Of Patients With Cirrhosis
      Poster Presenter
      Anand Mehta
      P-40: A Fucosylated Kininogen-Based Biomarker Panel Is Highly Accurate For Early Detection Hepatocellular Carcinoma In Patients With Cirrhosis: A Phase Iii Biomarker Evaluation
      Poster Presenter
      Bruno Sangro
      P-103: Exposure-Response Analysis For Nivolumab + Ipilimumab Combination Therapy In Patients With Advanced Hepatocellular Carcinoma
      Moderator
      Laura Kulik
      Hepatology & Liver Transplantation Professor, Medicine, Northwestern University Medical School, Chicago
      Poster Presenter
      Lijuan Liu
      P-32: Standardized Sampling And Reporting Protocol Is The Key To Improve Microvascular Invasion Detection Rate
      Poster Presenter
      Nathalie Ganne-Carrié
      P-66: Overall Survival Is Impacted By Liver Failure And Co-Morbidities Rather Than Etiology Of Cirrhosis In Patients With Hepatocellular Carcinoma Detected During A Surveillance Program
      Poster Presenter
      Petros Fessas
      P-109: Post-Registration Experience Of Nivolumab Therapy In Patients With Advanced Hepatocellular Carcinoma (Hcc): An International Study.
      Poster Presenter
      Philippe Merle
      P-115: Sequential Treatment With Sorafenib Followed By Regorafenib In Patients With Unresectable Hepatocellular Carcinoma (HCC): Interim Analysis Of The Observational REFINE Study
      Poster Presenter
      Richard Finn
      P-03: Ramucirumab For Patients With Advanced Hepatocellular Carcinoma And Elevated Alpha Fetoprotein Following A Non-Sorafenib Based Systemic Therapy: Interim Results From An Expansion Cohort Of The Phase 3 Reach-2 Study
      Poster Presenter
      Won Sohn
      P-56: Abnormal And Euthyroid Ranges Of Thyroid Hormones In Serum And Liver Cancer Mortality: A Cohort Study
      • Question & Answer

      Friday, September 11, 5:45 PM - 6:15 PM

        10 Top scored basic /translational e-Posters presenters  will participate on this LIVE Question & Answer session where participants and specialists will ask poster presenters about findings described in their poster. The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html ...
        Speaker(s)
        Moderator
        Amaia Lujambio
        Ph.D. Assistant Professor
        Icahn School of Medicine at Mount Sinai
        Poster Presenter
        Amanda Craig
        P-92: Characterization Of Chromatin Accessibility In Hepatocellular Carcinoma Cells Using Single Cell Atac Sequencing
        Poster Presenter
        David Repáraz
        P-81: Cold-Inducible Rna Binding Protein As A Vaccination Platform Against Hepatocellular Carcinoma
        Poster Presenter
        Emilien Loeuillard
        P-91: Dual Targeting Of Tumor Associated Macrophages And Immunosuppressive Granulocytic Myeloid-Derived Suppressor Cells Augments Pd-1 Blockade In Cholangiocarcinoma
        Poster Presenter
        Enric Vercher Herraez
        P-77: Identification Of Neoantigen-Reactive Tumor-Infiltrating T Cell In Hepatocellular Carcinoma.
        Poster Presenter
        Josep Corominas Argente del Castillo
        P-86: Activated Peripheral Blood Lypmphocytes Of Hepatocellular Carcinoma Patients (Hcc) Are Associated With Increased Risk Of Early Dermatologic Adverse Effects During Sorafenib Treatment
        Poster Presenter
        Laura Torrens
        P-76: Immune-Remodeling Effects Of Lenvatinib Plus Anti-Pd1 In A Murine Model Of Hepatocellular Carcinoma
        Poster Presenter
        Liangqing Dong
        P-70: Immunogenomic Characterization Of Multifocal Liver Cancer
        Poster Presenter
        Sarah Fritzsche
        P-90: Implications Of Notch3 Expression And Signaling For Cholangiocarcinogenesis
        Poster Presenter
        Vatche Agopian
        P-28: Purification And Digital Scoring Of Extracellular Vesicles For Detection Of Early-Stage Hepatocellular Carcinoma
        • Question & Answer

        Friday, September 11, 7:20 PM - 7:40 PM

          ILCA will recognise extraordinary achievements in liver cancer research across disciplines and support the professional development of four junior investigators in training. The award will be given for novel and significant liver cancer research across the fields of basic cancer research; translational cancer research; cancer diagnosis; the prevention of cancer; or... Read More
          Speaker(s)
          Session Chair
          Augusto Villanueva
          Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). ILCA Executive Secretary.
          Session Chair
          Bruno Sangro
          Director of the Liver Unit and Co-Director of the HPB Oncology Area at Clínica Universidad de Navarra in Pamplona, Spain. ILCA President (2019 - 2021)
          Session Chair
          Morris Sherman
          Professor of Medicine at University of Toronto. ILCA Past President
          Session Chair
          Sandrine Faivre
          Professor of Medical Oncology at the University Paris VII

            Saturday, September 12, 1:40 PM - 2:00 PM

              A summary conversation capturing the first day programme of presentations, panel discussions and the interactive dialogue at the conference day.  The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
              Speaker(s)
              Speaker
              Augusto Villanueva
              Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). ILCA Executive Secretary.
              Speaker
              Laura Kulik
              Hepatology & Liver Transplantation Professor, Medicine, Northwestern University Medical School, Chicago
              • Wrap-up Session

              Saturday, September 12, 3:00 PM - 4:00 PM

                4 oral presenters are allowed 10 minutes for each presentation, followed by 30 minutes Q&A for all presentations. Q&A will be moderated.   The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html ...
                Speaker(s)
                Oral Presenter
                Amaia Lujambio Goizueta
                O-08: Cooperation Between Distinct Cancer Driver Genes Underlies Inter-Tumor Heterogeneity In Hepatocellular Carcinoma
                Oral Presenter
                Geoffrey Fucile
                O-06: Supervised Learning Based On Tumor Imaging And Biopsy-Derived Transcriptomic Data Predicts Response Of Hepatocellular Carcinoma To Transarterial
                Moderator
                Jean Charles Nault
                Associated professor in Liver unit, Jean Verdier Hospital, Bondy, France. ILCA Communications Committee Chair.
                Oral Presenter
                Massih Ningarhari
                O-07: Telomere Length Is A Major Determinant Of Hepatocellular Carcinoma Diversity And A Therapeutic Target
                Oral Presenter
                Monika Lewinska
                O-05: Lysyl Oxidase Shapes Physical And Metabolic Interactions Between Tumor And Stroma In Cholangiocarcinoma Patients
                • General Session

                Saturday, September 12, 4:05 PM - 4:20 PM

                  15 minutes Question & Answer sessions with 3 speakers and moderators. Participants will be able to ask questions through the Q&A box.  The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
                  Speaker(s)
                  Moderator
                  Augusto Villanueva
                  Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). ILCA Executive Secretary.
                  Speaker
                  Daniela Sia
                  Assistant Professor in the Division of Liver Diseases, Department of Medicine, at Icahn School of Medicine at Mount Sinai (ISMMS)
                  Speaker
                  Gregory Gores
                  Executive Dean for Research, Physician Scientist
                  Mayo Clinic
                  Speaker
                  Jesper B. Andersen
                  Associate Professor and Group leader
                  University of Copenhagen · Biotech Research and Innovation Centre (BRIC)
                  • Symposium

                  Saturday, September 12, 4:20 PM - 4:35 PM

                    15 minutes question & answers with the speakers and moderator. Participants will be able to ask questions in writing using the Q&A box. Questions & Answers will be asked  from the on-demand  symposium programme below: Sequencing and Stratification of Systemic Therapy in HCC Symposium Session Chairs: Lorenza Rimassa (Italy), R. Kate Kelley (USA) The Growing... Read More
                    Speaker(s)
                    Speaker
                    David J. Pinato
                    Clinical Senior Lecturer in Medical Oncology
                    Imperial College London
                    Speaker
                    Josep Llovet
                    Prof.
                    IDIBAPS-HOSPITAL CLÍNIC / ICAHN SCHOOL OF MEDICINE
                    Session Chair
                    Lorenza Rimassa
                    Deputy Director Medical Oncology Unit Humanitas Cancer Center Humanitas Research Hospital - IRCCS, Milan, Italy
                    Speaker
                    Maria Reig
                    Hepatic Oncology (BCLC)
                    Hospital Clinic - Barcelona
                    Session Chair
                    R.Kate Kelley
                    Associate Professor of Clinical Medicine in the Department of Medicine at the University of California, San Francisco (UCSF) and the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC).
                    Speaker
                    Richard Finn
                    Professor of Clinical Medicine Division of Hematology/ Oncology UCLA David Geffen School of Medicine University of California, Los Angeles
                    Speaker
                    Stephen Chan
                    Associate Professor
                    Department of Clinical Oncology, The Chinese University of Hong Kong
                    • Symposium

                    Saturday, September 12, 4:40 PM - 4:55 PM

                      15 minutes Question & Answer session with the speakers of the Single Topic Workshops and moderator. Participants will be able to ask questions in writing using the Q&A box.  The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to... Read More
                      Speaker(s)
                      Speaker
                      Amaia Lujambio
                      Ph.D. Assistant Professor
                      Icahn School of Medicine at Mount Sinai
                      Speaker
                      Andrew Zhu
                      Director of Jiahui International Cancer Center, Director Emeritus of Liver Cancer Research at Massachusetts General Hospital Cancer Center, and Professor of Medicine at Harvard Medical School
                      Speaker
                      Eric Vibert
                      Academic surgeon at AP-HP specialized in the liver surgery and transplantation at Paul Brousse Hospital, Villejuif, France
                      Moderator
                      Jean Charles Nault
                      Associated professor in Liver unit, Jean Verdier Hospital, Bondy, France. ILCA Communications Committee Chair.
                      Speaker
                      Riccardo Lencioni
                      Director of the Division of Diagnostic Imaging and Intervention in the Department of Hepatology and Liver Transplantation at Pisa University Hospital in Italy
                      • Workshops

                      Saturday, September 12, 4:55 PM - 5:10 PM

                        15 minutes Question & Answer sessions with 2 speakers and moderator. Participants will be able to ask questions through the Q&A box.  The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
                        Speaker(s)
                        Moderator
                        Bruno Sangro
                        Director of the Liver Unit and Co-Director of the HPB Oncology Area at Clínica Universidad de Navarra in Pamplona, Spain. ILCA President (2019 - 2021)
                        Speaker
                        Florian Strasser
                        Head of Integrated Oncological Rehabilitation at Klinik Gais AG, Switzerland, and Senior Consultant Clinic for Medical Oncology and Hematology, Cantonal Hospital St. Gallen, Switzerland.
                        Speaker
                        Maria Die Trill
                        Coordinator of the Psycho-Oncology Unit of the Hospital Universitario Gregorio Marañón and Assistant Professor at the School of Psychology, Universidad Complutense of Madrid, Spain
                        • Symposium

                        Saturday, September 12, 5:15 PM - 6:45 PM

                          6 oral presenters are allowed 10 minutes for each presentation, followed by 30 minutes Q&A for all presentations. Q&A will be moderated.   The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html ...
                          Speaker(s)
                          Oral Presenter
                          Amit G. Singal
                          O-13: Patient-Reported Barriers Are Associated With Hcc Surveillance Receipt In A Multi-Center Cohort Of Patients With Cirrhosis
                          Oral Presenter
                          Federico Piñero
                          O-12: The Metroticket 2.0 And Afp Score Have Similar Performance To Predict Post-Lt Outcomes: Results Of A Multinational Multicentre Cohort Study.
                          Oral Presenter
                          Giulia Rovesti
                          O-09: Prognostic Role Of Pecs2 Index In Advanced Biliary Tract Cancer Patients Treated With First Line Chemotherapy: Training And Validation Cohorts.
                          Oral Presenter
                          Giuliana Amaddeo
                          O-15: A Multicenter, Cross-Section Study Of The Impact Of Covid-19 Pandemic On The Management Of Hepatocellular Carcinoma A High-Prevalence French Area.
                          Oral Presenter
                          Matthew Holzner
                          O-14: Is Repeat Resection For Recurrent Intrahepatic Cholangiocarcinoma Warranted? Outcomes Of An International Multicenter Analysis
                          Oral Presenter
                          Dr.  Parissa Tabrizian
                          O-10: Early Recurrence Of Hepatocellular Carcinoma Following Transplantation: Risk Score From A Multi-Institutional Study Of > 3000 Patients
                          Moderator
                          Sasan Roayaie
                          MD, FACS. General Surgery (board-certified)
                          • General Session

                          Sunday, September 13, 1:40 PM - 2:00 PM

                            A summary conversation capturing the second day programme of presentations, panel discussions and the interactive dialogue at the conference day.  The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
                            Speaker(s)
                            Speaker
                            Amaia Lujambio
                            Ph.D. Assistant Professor
                            Icahn School of Medicine at Mount Sinai
                            Speaker
                            Augusto Villanueva
                            Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). ILCA Executive Secretary.

                              Sunday, September 13, 3:00 PM - 4:30 PM

                                6 oral presenters are allowed 10 minutes for each presentation, followed by 30 minutes Q&A for all presentations. Q&A will be moderated.   The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html ...
                                Speaker(s)
                                Oral Presenter
                                Amit Singal
                                O-20: Improved Sensitivity For Early-Stage Hepatocellular Carcinoma Detection With A Novel Blood-Based Panel Of Methylated Dna And Protein Markers
                                Moderator
                                Amit Singal
                                Associate Professor at UT Southwestern Medical Center
                                Oral Presenter
                                Andrew X. Zhu
                                0-18: Alpha-Fetoprotein (AFP) Kinetics As A Potential Surrogate Biomarker In Patients (Pts) With Hepatocellular Carcinoma (HCC) Treated With Atezolizumab (Atezo) + Bevacizumab (Bev)
                                Oral Presenter
                                Han Xiao
                                O-16: Construction And Implementation Of An Artificial Intelligence Model For Microvascular Invasion Prediction Of Hepatocellular Carcinoma
                                Oral Presenter
                                Johann von Felden
                                O-19: Unannotated Small RNA In Circulating Extracellular Vesicles Detect Early Stage Liver Cancer
                                Oral Presenter
                                Takeshi Yokoo
                                O-17: Comparative Accuracy Of Abbreviated Mri Vs. Ultrasound For Detection Of Early-Stage Hcc In Patients With Cirrhosis
                                Oral Presenter
                                Xuehong Zhang
                                O-21: Inflammatory And Insulinemic Potential Of Diet And Lifestyle With Risk Of Hepatocellular Carcinoma
                                • General Session

                                Sunday, September 13, 4:35 PM - 4:50 PM

                                  The past few years have witnessed huge progress in the treatment of advanced HCC and the therapeutic landscape has been transformed. In order to provide comprehensive, up-to-date and readily accessible information about the latest treatment, ILCA have developed on-line guidance. The guidance will be launched at the ILCA 2020 conference... Read More
                                  Speaker(s)
                                  Speaker
                                  R.Kate Kelley
                                  Associate Professor of Clinical Medicine in the Department of Medicine at the University of California, San Francisco (UCSF) and the UCSF Helen Diller Family Comprehensive Cancer Center (HDFCCC).
                                  Speaker
                                  Tim Meyer
                                  Professor of Experimental Cancer Medicine at UCL and Honorary Consultant in Medical Oncology at the Royal Free and ULCH Hospitals. ILCA Communication Committee Chair.
                                  • Symposium

                                  Sunday, September 13, 4:50 PM - 5:05 PM

                                    15 minutes Q&A with speakers. Participants will be able to ask questions in writing using a Q&A box. The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
                                    Speaker(s)
                                    Speaker
                                    Amit Singal
                                    Associate Professor at UT Southwestern Medical Center
                                    Speaker
                                    Augusto Villanueva
                                    Assistant Professor in the Liver Cancer Program (Icahn School of Medicine at Mount Sinai, New York). ILCA Executive Secretary.
                                    • Symposium

                                    Sunday, September 13, 5:10 PM - 6:40 PM

                                      6 oral presenters are allowed 10 minutes for each presentation, followed by 30 minutes Q&A for all presentations. Q&A will be moderated.   The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html ...
                                      Speaker(s)
                                      Oral Presenter
                                      Anthony B. El-Khoueiry
                                      0-24: Outcomes For Patients With Advanced Hepatocellular Carcinoma And Child-Pugh B Liver Function In The Phase 3 Celestial Study Of Cabozantinib Versus Placebo
                                      Oral Presenter
                                      Bruno Sangro.
                                      O:27: Nivolumab After Selective Internal Radiation Therapy (Sirt) Using Sir-Spheres Resin Microspheres In Patients With Hepatocellular Carcinoma: The Nasir-Hcc Trial
                                      Oral Presenter
                                      Joong-Won Park
                                      O-26: Proton Beam Radiotherapy Versus Radiofrequency Ablation Treatment In Patients With Recurrent Hepatocellular Carcinoma: A Randomized Controlled Phase 3 Non-Inferiority Aproh Trial
                                      Oral Presenter
                                      Neil Mehta
                                      O-23: Transarterial Chemoembolization And Radioembolization Are Similarly Effective In Achieving Successful Hepatocellular Carcinoma Downstaging In The Multicenter Evaluation Of Reduction In Tumor Size Before Liver Transplantation (Merits-Lt) Consortium
                                      Oral Presenter
                                      Pierre Nahon
                                      0-25: Radiological And Pathological Response To Neoadjuvant Nivolumab In Patients With Bclc A Hcc Treated By Curative Percutaneous Irreversible Electroporation: Preliminary Report From The French Multicentre Phase 2 Nivolep Trial.
                                      Oral Presenter
                                      R. Katie Kelley
                                      O-22: The Novel Regimen Of Tremelimumab In Combination With Durvalumab Provides A Favorable Safety Profile And Clinical Activity For Patients With Advanced
                                      Moderator
                                      Tim Meyer
                                      Professor of Experimental Cancer Medicine at UCL and Honorary Consultant in Medical Oncology at the Royal Free and ULCH Hospitals. ILCA Communication Committee Chair.
                                      • General Session

                                      Sunday, September 13, 6:40 PM - 6:50 PM

                                        The official hour of the ILCA 2020 Virtual Conference is CEST ( Central European Summer Time). Please use the link to convert to your local time   https://www.timeanddate.com/worldclock/converter-classic.html...
                                        Speaker(s)
                                        Speaker
                                        Bruno Sangro
                                        Director of the Liver Unit and Co-Director of the HPB Oncology Area at Clínica Universidad de Navarra in Pamplona, Spain. ILCA President (2019 - 2021)
                                        • Closing Session